Chainbase vs Mitosis — how do they compare? Chainbase trades at Rp1,165 (market cap Rp423,7M, Rp73,84M 24h volume), while Mitosis trades at Rp389.4 (market cap Rp70,65M, Rp79,19M 24h volume). The key difference: Chainbase is far larger — about 6× Mitosis's market cap, and Chainbase's circulating supply is 362,6M / 1B C (37%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Chainbase for 9 Days and Mitosis for 19 Days on average.
| C | MITO | |
|---|---|---|
Market Cap | Rp423,7M | Rp70,65M |
Volume (24h) | Rp73,84M | Rp79,19M |
Circulating Supply | 362,6M / 1B C (37%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 9 Days | 19 Days |
What Pluang investors did over the last 30 days
Latest headlines on both assets
Chainbase is developing the Hyperdata Network for AI, establishing a foundational layer for the DataFi era. This network converts fragmented on-chain signals into structured, verifiable, and AI-ready data, facilitating seamless collaboration among agents, applications, and humans. Chainbase empowers a decentralized data economy where data is treated as capital—composable, monetizable, and accessible to everyone.
Read more on C →Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →